Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.
The present invention is concerned with a process
for the determination of substrates or enzyme activities
with the use of a redox re~ction as measurement reaction
and is also concerned with a reagent for carrying out
this process.
In clinical and pharMaceutical chemistry, bio-
chemistry and foodstuff chemistry, redox reactions are
of great interest for the determination of en~yme or
substrate concentrations. These reactions can be evalu-
ated by photometric measurements. If, in addition to the
redox components of interest, the test system contains
other reducing substances, disturbances can occur.
Ascorbic acid is found especially frequently in sample
material. Since it is a strong reducing agent, it gives
. .~
rise to disturbances when investigating phanmaceuticals
or physiological fluids, such as serum or urine, ascorbic
acid-containing plant juices or other foodstuffs which
contain ascorbic-acid or to which ascorbic acid has been
added. Thus, for example, it is known that the following
reactions are disturbed by ascorbic acid:
A. reactions in which hydrogen peroxide and a hydrogen
donor are reacted wit'n peroxidase (PoD3 are disturbed
by the reaction:
ascorbic acid + H202 POD~ dehydroascorbic acid + H20
B. reactions in which tetrazolium salts are reduced with
reducing agents to give formazanes are disturbed by
the reaction:
ascorbic acid + tetrazolium salt
formazane + dehydroascorbic acid
C. reactions in which phenols are oxidatively coupled with
-2-
,
." ~ ' ~' ' ..
~343~3
nucleoph]lic reagents are disturbed because ascorbic acicl
gives rise to side reactions, which have not yet been
elucidated, so that non-uniform coupling products
are formed, the absorption behaviour of which deviates in
normal and ultra-violet light from the coupling products
normally formed.
Conventional oxidation methods are, as a rule, unsuitable
for the removal of ascorbic acid from the sample material.
Oxidation agents also attack and destroy substrates and enzymes.
Their reduction products, which are mostly di- and trivalent
metal ions, frequently inhibit the enzymes used for the indica-
tor reaction. The destruction of ascorbic acid in the presence
of oxygen necessitates the use of strongly alkaline media, for
example a 25% aqueous solution of sodium hydroxide. This also
~; leads to the destruction of substrates and enzymes.
`~~ Therefore, the problem forming the basis of the present
... .
- invention is to provide a process for the determination of
; substrates or enzyme activities, with the use of a redox reac-
tion as measurement reaction, which is no longer disturbed by
- 20 ascorbic acid.
According to the present invention, this problem is solved
by adding ascorbate oxidase to the reaction batch.
~ . ,
Ascorbate oxidase catalyses the reaction:
~; ascorbic acid + 1/2 2 ascorbate oxidase
dehydroascorbic acid + H20
According to the statements in the literature concerning
.
ascorbic acid oxidase, it was to have been expected that this
enzyme could not be employed for the
~
~ _3_
.~ .
,,
:.;..
., ., ~ , , .
purpose according to the present inven-tion. Thus, all
previously obtained enzyme preparations produce hydrogen
peroxide in a side reaction. At the same time, ascorbate
oxidase undergoes a very rapid inactivation which is
ascribed to the simultaneously formed hydrogen peroxide
(Biochemical Copper Proceedings Symposium Harriman, New
York 1965, pp. 305 - 337). This also applies to the most
highly purified preparations which, in the ultracentrifuge
and by electrophoresis, no longer show the presence of
any impurities (Biochem. 4, 1362-1370/1965). ~he reaction
inactivation is ascribed to the formation o~ hydrogen
peroxide (Biochem. Biophys. Acta 5~, 427 to 439/1962).
According to the calculations of the lat~er authors, lU
ascorbate oxidase in 1 mMol/litre ascorbic acid solution
can produce 0.7 x 10 2 mMol/litre of hydrogen peroxide,
such ascorbate concentrations being frequently present
in sample solutions. The hydrogen peroxidè formed is
certainly available for enzymatic reactions, which has
been demonstrated in the case of, for example, catalase.
In the system:-
hydrogen donor + ~202~PoD~ coloured material ~ 2H20
used for the photometric determination of hydxogen ,~
.,
peroxide, at a molar extinction coefficient of about
20 cm / ~Mol, it brings about an extinction difference
of 0.14. Since the measurement range of normal photo-
metric reactions extends from about 0.01 - 1.00, this
gi~es rise to an unacceptable error. In the same way,
reactions are disturbed in which, instead of hydrogen
peroxide, use is made of organic hydroperoxides and
instead of POD, use is made of haemoglobin or of other
;
-4-
., ~ .
-`:
:~8~3~
oxidation catalysts.
However, apart from these errors brought about by
hydrogen peroxide, it is known from the above last-
mention~d literature reference that the reaction of the
ascorbic acid already comes to a stop long before its ~ .
complete removal.
This would be especially serious in the case of all
those redox reactions in which hydrogen peroxide is formed
since this hydrogen peroxide would certainly, on the one
hand, further accelerate the inactivation of the enzyme
and, on the other hand, the new formation of hydrogen
peroxide by the ascorbate oxidase itself leads to
completely unpredictable phenomena. Therefore, it is
most surprising that, contrary to expectations, it is
possible completely to remove the disturbances brought ;~
about by the presence of ascorbate by the addition of
ascorbate oxidase, without other disturbances arising
which would again nullify the advantage of:the ascorbate
removal.
.,
The process according to the present invention is
preferably used in the case of enzymatic reactions,
especially those in which hydrogen peroxide is formed
and thus in the case of reactions which are catalysed
by oxidases, such as'glucose oxidase, uricase, cholesterol
oxidase and the like, as w~ll as in the case of reactions
in which tetrazolium salts are reduced and in the case of
reactions in which phenols are oxidatively coupled with
nucleophi:Lic reagents. The amount of ascorbate oxidase
added depends upon the amount of ascorbic acid to be
:
e~pected in the sample. As a rule, O.002 to 100 U
; _5_
39~
ascorbate oxidase/ml. and preferably 0.01 to 30 U/ml.,
are added to the -test batch. The pH value of the reaction
depe~ds, in the first place, upon the pH value which is
necessary for the other participating enzyme or enzymes.
pH values of from 4.0 to 8.5 are usually appropriate for
the process of the present invention. Accordlng to the
- invention, it is especially preferred to use an ascorbate
oxidase obtained from small marrows (Curcurbita ~e~
medullosa). However, ascorbate oxidase of other origin
can also be used.
The present invention also provides a reagent for the
determination of substrates or enzyme activities, com-
prising a system for the determination of a substrate
or enzyme with a redox reaction as measurement reaction,
the reagent additionally containing ascorbate oxidase.
Preferred reagents of this type contain, when
glucose is the substrate to be determined, peroxidase,
glucose oxidase, o-dianisidine or azino-di-3-ethylbenzyl-
thiazoline-6-suIphonate, together with buffer, or hexo-
kinase (~), glucose-6-phosphate dehydrogenase (G6P-DH),
diaphorase, nicotinamide-adenine-dinucleotide phosphate ~ ;
(NADP), a tetrazolium salt, such as 3-(4-iodophenyl)-2-
(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (INT)
and buffer. When uric acid is the substrate to be
determined, the system preferabIy comprises peroxidase,
uricase, a phenol1 such as 2,4-dichlorophenol, amino-
antipyrine and buffer. In the case of the determination
of glutamate, the system preferably comprises glutamate
dehydrogenase (GlDH), diaphorase, nicotinamide-adenine-
dinucleotide (NAD~, INT and buffer. For the determin-
-6-
: .
343~3
ation of -tyrosine, the system preferably comprises
tyrosinase, 3-methyl-6-po-tassium sulphonyl-benzthiazolone-
2-hydrazone and for the detenmination of pyrocatechol,
the system preferably comprises diphenol oxidase and
3-methyl-6-potassium sulphonyl-benzthiazolone-2-
hydrazone, in each case together with a buf~er. All
these systems for the determination of substrates are
known. However, there can also be used instead other
known systems for the determination of substrates or
enzymes within the scope of the reagent according to
the present invention.
The present invention is also of especial irnportance
for use in the field of rapid diagnostics. As a rule,
such rapid diagnostics contain the various reagents needed
-
for carrying out the process either impregnated in an
absorbent carrier or applied" together with an appropriate
binding agent, to a carrier filmO A preferred embodi-
.
mental form is the addition of the ascorbate oxidase to ~ ~
the mixture of the other reagents, with subsequent impreg- --
nation into an absorbent carrier~ In this way, there can
be obtained test papers which are practically not dis-
turbed, for example, by ascorbic acid when used for the
detection of glucose in urine (for example, according to
~erman Patent Specification No. 23 38 932) or of blood
in urine (for example, according to German Patent Spec-
ifications ~os.2,460,903 or 2,235,152) or of blood in
faeces. That the ascorbate oxidase in test papers for
the detection of blood in urine remains capable of
functioning and is also storage-stable is most su~prising
because these test papers contain large amounts of organic
hydroperoxides which, similarly to hydrogen peroxide,
-7-
. - ~ ....... .
. :: ,
.~'~:;'' ' ', ' : ,
3~3
would have been expected to cause an inactivation of the
ascorbate oxidase.
The ascorbate oxidase can, however, also be applied
to a separate carrier which is then combined with the
carrier for the other reagents, for example, laid there-
over, stuck thereto or jointly sealed in between approp-
riate materials~. In this case, an especially preferred
carrier for the ascorbate oxidase is a so-called water-
soluble paper (for example, according to German Patent
Specification ~o.2,436,598) which allows the colour
reaction to be observed especially well on the carrier
paper containing the other reagants. This embodiment is ;~-
especially advantageous when, in the reagent combination,
substances are present which are incompatible with the
ascorbate oxidase, for example strongly acidic reagents ~ -
such as are used in processes for the determination of
urobilinogen, bilirubin and nitrite.
In the case of the above embodiments, there can be
used up to 5000 U and preferably up to 2000 U ascorbate
, .
oxidase per ml. impregnation solution for the preparation
of the reagent. In general, less than 1 U/ml. will not
ensure the desired effect.
Furthermore, separate zones of a carrier material
can also be impregnated with the ascorbate oxidase or the
other-test reagents. In this case, the carrier is prefer-
. .
ably brouyht into contact with the solution to beinvestigated in such a manner that the solution first
comes into contact with the ascorbate oxidase-containing
; zone and from there is drawn into -the zone which contains
; the other test reagents.
,
'''
~' :
,
L3~3
According to a further ernbodiment, the ascorbate
ox.idasiie can be bound to an insoluble carrier material by ~ -
methods known for enzyme fixing, methods of this type
being described, for exc~ple, in German Patent Specific-
~; ations Nos.1,768,512, 2,128,7~3; 2,260,185: 2,260,184;
: 2,426,988, 2,603,158 ancl 1,915,970.
-~ . The process according to the present invention i5
preferably used for the determination of glucose with
peroxidase, glucose oxidase and o-dianisidine or 2,2~-
. azino-di-3-ethylbenzthiazoline-5-sulphonate (ABTS), for
the determination of glucose by the hexokinase/glucose
- 6-phosphate dehydrogenase method, for the detection of
urlc acld by means of phenol, aminoantipyrine, peroxidase
and uricase, for the determination of tyrosine or pyro-
catechol by means of SMBT~I (4-methyl-6-potassium sulphonyl- -
~
~..,
~`i benzthiazolone-2-hydrazone~ and tyrosinase or diphenol
`~l oxidase, respectively.
The following Examples are given for the purpose
--: of illustrating the present invention~
i
Example 1. ~ :`
.- ~ Determination of glucose with o-dianisidine,
:~ peroxidase (POD) and glucose oxidase (GOD), measured in
`~ a photometer; wavelength 432 nm, measurement temperature:
25C
:-,i ~
~ . . .
., :
", ~
.~., :~
:,
; i ~
.,
~i
i ~
i", ~
_ g _
,, .
.,
3~3
cuvette No. 1 2 3 4 5
pH 7.01 M 2.5 2.5 2.5 2.5 2.5
o-dianisidine 0.1 0.1 0.1 0.1 0.1
5 mg./ml
POD, 180 U/ml. 0.05 0.05 0.050.05 0.05
glucose solution 0 03 0 03 0 03 0 03 0 03
1 mg./ml.
ascorbic acid 0.1 0.01 0.1 0.01
solution 10 mM
water 0.12 0.02 0.11 - 0.09
500 U/ml. 0.02 0.02
.
incubate for 1 min.at 25C., read off El, then start with
GOD 70 U/ml~ 0.1 0.1 0.1 0.1 0.1
incubate for 30 min. at 25C., read off E2, calculate
~E from E2 E
~E 0~541 0.010 00316 0.540 0.543
Cuvette 1 corresponds to an undisturbed measuremen~
(no ascorbic acid). Cuvettes 2 and 3 show that 1 or 0.1
~Mol ascorbate practically completely inhibit or 41.5%
inhibit the test and cuvettes 4 and 5 show the complete
destruction of these ascorbate concentrations by the
addition, in each case, of 10 U ascorbate oxidase.
.
Detection of glucose with 2,2'-azino di-(3-ethyl-
benzthiazoline-6-sulphonate) (ABTS), POD and GOD in a
photometer, wavelength: 432 nm' measurement temperature:
:`
25C
`~
:::
- --10--
.:
.~'. '' '. ` ~
35~
. . _
cuvette No. l 2 3 4 5
phosphate buffer 2.75 2~75 2.75 2.7S 2.75
ABTS 50 mM 0.05 0.05 0.05 0.05 0.05
POD 250 U/ml. 0.02 0.02 0.02 0.02 0.02
glucose solution
0.1 mg./ml. 0.1 0.1 0.1 0.1 0.1
solution lmM 0.1 0.01 0.1 0.01
water 0~12 0.02 0.11 - 0.09
ascorbate oxidase
500 U/ml. ~ ~ - 0.02 0.02
incubate for l min. at 25C., read off El, start with
GOD 70 U/ml. 0.1 0.1 0.1 0.1 0.1
~
incubate for 30 min. at 25C., read off E2, calculate
~E from E2-E~
., .
~E 0.50S 0.000 0.40 0.502 0.504 -~
::.
Cuvette l corresponds to an undisturbed measurement
(no ascorbate). Cuvettes 2 and 3 show that 0.1 or 0.01
~ Mol ascorbate completely inhibit or 21% inhibit the test
and cuvettes 4 and 5 show the complete destruction of
these ascorbate concentrations by the addition, in each ,
. .
~- case, of 10 U ascorbate oxidase.
Example 3.
~ Detection o~ uric acid by means of phenol, amino-
- antipyrine, POD and uricase in an automatic analyser
; (AutoAnalyser).
; ~ nciple
uric acid ~ 2 ~ H20 _ ~ e~ allantoin ~ ~22
.~ -11-
~ ,
:~"'`
.
3~3
2H202 + 2,4-dichlorophenol -~ 4-aminoantipyrine PO
quinoid coloured material ~ 2H20
Preparation of the solutio _
l. Ascorbate oxidase rea~ent
_ .
In 600 ml. double distilled water, there is dissolved
the content of flask 1 and 0.3 ml. Brij-35 is added. The
solution can be stored in a dark bottle at about 4C. for
four weeks and at about 25C. one week.
2. Uricase reaqent.
In 800 ml. double distilled water, there is dissolved
the content of flask 2 and 2.0 mlO Brij-35 are added. ~he
: ~
solution can be stored in a dark bottle at about 4C. Eor
four weeks and at about 25 C. for one week.
_. ;
1. 50 mM phosphate buffer, pH 5.6
ascorbate oxidase ~ in the amounts which can be seen
from Fig.2 of the accompanying drawings.
2. 31 m~ tris-(hydroxymethyl3-aminomethane/citric acid,
pH 8.9
uricase ,~ 0.08 U/ml. ~ ;
.- ,. .
POD ~ 0.015 U/ml. `
3.0 mM 2,4-dichlorophenol ;
4.0 mM 4-aminoantipyrine
For the carrying out oE the determination, the flow
- systems of the automatic device is assembled according to
the flow diagram illustrated in Fig.l of the accompanying ;
drawings.
Fig.2 of the accompanying drawings s~nmarises, in
graphic :Eorm, the e~perimen~al results obtained.
~ ~ rad0 In4
'.~
.
-12-
. , .
. .
.-:, :
. ~ : , , -
393
Exam~e 4.
.
Detection of glucose with ~/G6P-DH, NADP, IN~ and
diaphorase in a photometer; measurement wavelength:
492 nm' incubation temperature: 25G.
:
cuvette No. 1 2 3
phosphate buffer, pH 7.5 O.lM1.7 1.7 1.7
NADP/INT each 1 mg./mlØ1 0.1 0.1
diaphorase 5 U/ml. 0.1 0.1 0.1
glucose solution 0.05 mg.~mlØ1 0.1 0.1
ascorbate solution 10 mM - 0.01 0.01
` ascorbate oxidase 35 U/ml. - - 0.03
... :
water 0.04 0.03
incubate for 3 min. at 25C., read off El, start with
.'~`' ~ .
~ HK/G6P-DH solution each 56 U/ml. 0.05 0~05 0.05
.. -- ... - _ _ _ ,. _ .
incubate for i5 min., read off E2, calculate QE from
~ E2-El
- QE 0.234 0.307 0.230 `
; .
; Cuvette 1 corresponds to an undisturbed measurement,
cuvette 2 shows that 0.01 ~Mol ascorbate gives a test
result which is 34% too high and cuvette 3 shows that
1 U ascorbate oxidase completely overcomes this disturbance.
Example 5.
Determination of ylutamate by means of GlDH, NAD/
INT/diaphorase in a pho~ometer, measurement wavelength
492 nm; temperature 25C.
.
-13-
.,
,~ ............ .
::: . :
1L3~3
_
cuvette No. 1 2 3 4 5
phosphate buffer, 1.3() 1.20 1.29 1.18 1.27
glutamate solution 0.1 0.1 0.1 0.1 0.1
0.2 mg./ml.
ascorbate solution 0 1 0.01 0.1 0.01
ascorbate oxidase 0.02 0.02
incubate for 3 min. at 25C., then pipette into the
individual cuvettes
0. 2 M TRA, 0.05 M ~-,
potassium phosphate 1.0 1.0 1.0 1.0
1.5% Triton-X-100
NAD solution 5 mg/ml. 0.2 0.2 0.2 0.2 002
diaphorase solution 0.05 o,05 o,05 0.05 0.05 ~ ,
GlDH 1000 U/ml.O.05 0.05 0.05 0.05 0.05
. ~ :
read off El, start reaction with
- - - - - -- :
I~T solution, 2 mg/mlO 0.05 0.05 0.05 0.05 0.05
incubate for 15 min. at 25C., read off E2, calculate
~E from E2-El
~ ~E 0.184 1.560 0.380 0.186 0.182
- Cuvette 1 corresponds to an undisturbed measurement,
cuvettes 2 and 3 show that 0.5 or 0.05 ~ ol ascorbate
give test results which are 700 or 100% too high and
cuvettes 4 and 5 show the complete removal of this dist-
-^ urbance by 2 ~ ascorbate oxidase.
Determination of tyrosine with 3-methyl-6-potassium
~ -14-
,:
. .
~013~393
sulphonyl-benzthia~olone-2~hydrazone (SMB'm) and tyro-
sinase in a photometer, measurement wavelength 492 nm,
measurement temperature 25C~C.
cuvette No. 1 2 3
phosphate buffer, pH 5.2 2.77 2.77 2.77
0.25 M
SMBTH 0.lM O.05 0.05 0.05
ascorbic acid solution 0.1 0.1
water 0.12 0.02
ascorbate oxidase 500 U/ml. - - 0.02
tyrosinase 60 U/ml. 0.05 0.05 0.05
incubate for 1 min. at 25C., read off El, start with
tyrosine 2 mM 0.05 0.05 0.05
.,;. - . .......... . .
incubate for 1 hr. at 25C., read off E2,,calculate ~E
,~ from E2-El -
,,~
~ ~ ~E 1.113 0.728 1.100
_ ~
,~ Cuvette 1 corresponds to an undisturbed measurement, ~-
. . ~
in cuvette 2, 1 ~Mol ascorbate lowers -the theoretical
value by 35% and in cuvette 3 this disturbance is completely
removed by 10 U ascorbate oxidase.
~ Example 7
; Determination of pyrocatechol wikh SMBTH and
- diphenol oxidase.
,~ :
,
,.:
' :~
.`j, :
-15-
, .. .. . . . .
3~3
cuvette No. 1 2 3
phosphate bufEer, 0.25 M 2.80 2.70 2.68
SMBTH 0.1 M - 0.05 0.05 0.05
pyrocatechol 0.5 M 0.10 0.10 0.10
ascorbate solution 20 mM - 0.1 0.1
ascorbate oxidase 500 U/ml. - - 0.02
incubate for l min. at 25~C., read off El, start with
,, ,_ , ,
diphenol oxidase 200 U/ml. 0~05 0.05 0.05
,
incubate for 17 min. at 25C., read off E2, calculate QE ~
. ~ .
frcm E2-El
~E 0.890 0.485 0.896 --
Cuvette 1 corresponds to an undisturbed measurement,
in cuvette 2, 2 ~Mol ascorbate lowers the theore-tical
value by 47% and in cuvette 3 this disturbance is
completely removed by 10 U ascorbate oxidase.
~ Example 8.
-- Test paper for the detection of ~lucose ~n the urine.
Filter paper is impregnated with a solution of the
- following composition and dried at 50C.:
;~ 1.2 M citrate buffer pH 5 50.0 ml.
,~
9-(~-dimethylaminopropyl)-6-chloro- -
3-aminocarbazole dihydrochloride 0'75 g'
glucose oxidase ~104 U/mg.) 0.25 g.
peroxidase (63 U/mg.) 0.05 g.
ascorbate oxidase ~100 U/mg.) l.00 g.
- water lO0.0 ml.
The test paper reacts with glucose-containing urines
. .~
- -16- ~ ;
., ,
:' . : : .,, ~
3g3
with red-orange to black-red colour shades. After a
reaction time of 2 minutes, urines with the same glucose
contents but also with ascorbic acid contents of up to
150 mg./dl. give practically the same reaction colours.
With test papers of analogous cornposition but with-
:
out ascorbate oxidase, depending upon the glucose content,
the reaction colours are weakened or completely suppressed
in the case of ascorbic acid concentrations above
50 mg./dl.
.` ~ .
~ Test paper for the detection of blood in the urine.
- Filter paper is successively impregnated with the
;. ~ :. ,
following solutions and dried at 40C.
Solution 1
1.2M citrate buffer pH 5.25 35.0 ml
ethylenediamine-tetraacetic acid 0 1 g
disodium salt
dioctyl sodium sulphosuccinate 0.5 g.
2,5-dimethylhexane-2,5-dihydro-1 6
peroxide ~about 70%) " g'
phosphoric acid trimorpholide 12.7 gO
ascorbate oxidase (100 U/mg.) 0.3 g.
methanol 30.0 ml
water ad lOOo O ml
Solution 2
~: ~ ... ...
3,3a,5,5J-tetramethylbenzidine 0,3 g.
phenanthridine 0.2 g.
toluene/petroleum ether (30:70 v/v) ad 100.0 ml.
With this test paper, there can be detected the
.
presence of 5 erythrocytes/mm3 in the urine, even in the
~;~ presence of 30 to 50 mg. ascorbic acid/100 ml. With a
test paper o~ the same composi~ion but without ascorbate
-
-17-
.
: ~,
. ..... . .
.. . . :
: :'.~ . .. .
1~34~3
oxidase, this detection is no longer possible even in the
presence of only 10 - 20 mg. ascorbic acid/100 ml.
Example 10
Test paper A
Test paper as in Example 9 but without ascorbate
oxidase.
.
Test paper B
Water-soluble carboxymethylcellulose paper (weight
60 g.jm2) is impregnated with a solution of 20% glacial
acetic acid in methanol for the purpose of neutralisation
and then dried. Thereafter, it is sprayed with an aqueous
solution of ascorbate oxidase (103 U/ml.) and dried
immediately.
Test paper B is laid upon test paper A and both
are sealed in together between a polyester film and a
nylon mesh. The urine to be,investigated is dropped on
to the test strips so produced.
The results obtained are analogous to those of
Example 9. ,
Test paper for the detection of blood in_faeces
Filter paper is successively impregnated with the
following solutions and dried at 40C.
Solution 1
1.2 M citrate buffer, pH 5.2510 ml. -~
ascorbate oxidase 100 U/mg. 0.3 g. ~ ~'
water ad 100.0 ml.
Solution 2 "
_ __
gum guaiac 3 g.
, toluene ad 100.0 ml.
::
, -18-
. :
'~
.
3~3
The solution is filtered and the filtrate is used
for the impregnation.
The test paper obtai:ned is coated with faeces. If,
on the rear side, 'chere is dropped on a 3% aqueous
solution of hydrogen perox.ide, then a blue coloration
is obtained when the faeces contain about 2% blood.
This coloration also occurs in the case of ascorbic acid-
containing faeces (about 15 mg./100 g.), whereas it does
not occur when the test paper does not contain ascorbate
oxidase.
.~
':
,
,
~ ' '
'
, . .
,, ; --19--
.:
.~ ~ , . . .